FDA product code QXY: Oscillometric-Based, Over-The-Counter, Atrial Fibrillation Notification Feature

QXY is the FDA product code for oscillometric-based, over-the-counter, atrial fibrillation notification feature. It is a Class II device, regulated under 21 CFR 870.1135 and reviewed by the Cardiovascular panel. Devices under QXY reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

An oscillometric-based, over-the-counter, atrial fibrillation notification feature is a software algorithm for analysis of signals from an oscillometric, non-invasive blood pressure measurement system to screen for possible atrial fibrillation in the device user.

Classification

FieldValue
Device nameOscillometric-Based, Over-The-Counter, Atrial Fibrillation Notification Feature
Device classClass II
Regulation21 CFR 870.1135
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)

Recalls for QXY devices

openFDA lists no recalls for product code QXY.

Frequently asked questions

What is FDA product code QXY?

QXY is the FDA product code for oscillometric-based, over-the-counter, atrial fibrillation notification feature. It is a Class II device, regulated under 21 CFR 870.1135 and reviewed by the Cardiovascular panel.

What device class is QXY?

Class II, regulation 21 CFR 870.1135. Typical premarket route: 510(k).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times